James Hitchin joined Charnwood Molecular in December 2016 as Head of Medicinal Chemistry. James brings extensive experience from across multiple therapeutic areas in drug discovery, having previously held senior positions at SAFC Pharma, Pfizer Pharmaceuticals and KemFine Oy. Prior to joining Charnwood, James was Senior Medicinal Chemist at the Cancer Research UK Manchester Institute, where he worked on various target classes, including kinases and epigenetic targets. James has led numerous projects from hit identification right through to lead optimization and beyond, and has an in depth knowledge of modern drug discovery, as exemplified by his impressive publication record.
